ASSEMBLY BIOSCIENCES, INC. (ASMB) Financial Statements
ASSEMBLY BIOSCIENCES, INC. (ASMB) reported trailing twelve-month revenue of $74.8M (up 125.1% year on year) and net income of -$42000 as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: -$38.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ASMBASSEMBLY BIOSCIENCES, INC.Follow ASMB — free
—
Price chart with a free account
- Market cap
- 404.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 14.8 | 16.0 | 79.1 | 6.3 | 7.2 | 28.5 | 72.3 | 74.8 | |
| Research & development | 72.7 | 85.8 | 106.8 | 68.5 | 48.9 | 55.9 | 64.8 | 63.7 | |
| Operating income | -92.7 | -102.7 | -64.8 | -132.7 | -64.6 | -45.4 | -12.1 | -8.8 | |
| Pre-tax income | -89.7 | -98.4 | -62.2 | -132.4 | -61.2 | -39.8 | -6.1 | — | |
| Income tax | 1.1 | -0.8 | 0.0 | -2.5 | 0.0 | 0.3 | 0.0 | — | |
| Net income | -90.8 | -97.6 | -62.2 | -129.9 | -61.2 | -40.2 | -6.1 | -0.0 | |
| Diluted EPS ($) | -3.98 | -3.72 | -1.75 | -3.00 | -13.38 | -6.69 | -0.55 | -0.00 | |
| Diluted shares (mn) | — | — | — | — | 4.6 | 6.0 | 11.2 | — |
USD millions · SEC XBRL
ASSEMBLY BIOSCIENCES, INC. — questions
- What is ASSEMBLY BIOSCIENCES, INC.'s revenue?
- $74.8M over the twelve months to 2026-06-30, up 125.1% year on year, from its 10-Q and 10-K filings.
- What is ASSEMBLY BIOSCIENCES, INC.'s net income?
- -$42000 over the twelve months to 2026-06-30.
- What is ASSEMBLY BIOSCIENCES, INC.'s free cash flow?
- -$38.6M over the twelve months to 2026-06-30.
- What are ASSEMBLY BIOSCIENCES, INC.'s diluted earnings per share?
- $-0.00 over the twelve months to 2026-06-30.
Every figure on this page comes from ASSEMBLY BIOSCIENCES, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.